A device for the removal of heavy metals and heavy metal complexes, such as thimerosal, from medications is provided wherein the device comprises a solid support having at least one substantially purified metallothionein protein associated therewith.
대표청구항▼
1. A system for the removal of thimerosal from a volume of medication, the system comprising: a container containing a volume of a thimerosal-containing medication comprising a plurality of doses of said medication;a solid support having associated therewith at least one substantially purified metal
1. A system for the removal of thimerosal from a volume of medication, the system comprising: a container containing a volume of a thimerosal-containing medication comprising a plurality of doses of said medication;a solid support having associated therewith at least one substantially purified metallothionein protein, or a portion thereof;passing said thimerosal containing-medication through said solid support into dosing vials, wherein said at least one substantially purified metallothionein protein binds said thimerosal from said medication resulting in a substantially thimerosal-free medication in said dosing vials. 2. The system of claim 1 wherein said medication is a vaccine, immunogenic composition, liquid pharmaceutical composition, colloidal pharmaceutical composition, suspension pharmaceutical composition, aerosol, or dry powder. 3. The system of claim 1 wherein said solid support is a filter, membrane, nanoparticles, beads, solid support particulates, or polymer coating. 4. The system of claim 3 wherein said at least one substantially pure metallothionein protein is associated with a plurality of beads or nanoparticles. 5. The system of claim 1 wherein said solid support comprises a biocompatible polymer. 6. The system of claim 5 wherein said biocompatible polymer is a fluorinated polymer, polyolefin, polystyrene, substituted polystyrene, polysulfone, polyester, polyacrylate, polycarbonate; vinyl polymer, copolymer of butadiene and styrene, fluorinated ethylene-propylene copolymer, ethylenechlorotrifluoroethylene copolymer, nylon, or mixtures thereof. 7. The system of claim 3 wherein said solid support is a filter. 8. The system of claim 1 wherein said at least one substantially purified metallothionein protein, or a portion thereof, is from a mammal, fish, mollusk, echinoderm, crustacean, reptile, nematode, grain, plant, yeast, or fungus. 9. The system according to claim 8 wherein said crustacean is brine shrimp (Artemia). 10. The system of claim 1 wherein said metallothionein protein has an amino acid sequence of SEQ ID NO. 2, SEQ ID NO. 4, SEQ ID NO. 11, SEQ ID NO. 12, SEQ ID NO. 13, SEQ ID NO. 14, SEQ ID NO. 15, SEQ ID NO. 16, SEQ ID NO. 17, SEQ ID NO. 18, SEQ ID NO. 19, SEQ ID NO. 20, SEQ ID NO. 21, SEQ ID NO. 21, or SEQ ID NO. 23. 11. A method of removing thimerosal from a medication to be administered to a subject comprising: contacting a volume of a thimerosal-containing medication with at least one substantially purified metallothionein protein associated with a support; andseparating the support having thimerosal bound thereto from the thimerosal free medication; and portioning the thimerosal-free medication into dosing vials.
연구과제 타임라인
LOADING...
LOADING...
LOADING...
LOADING...
LOADING...
이 특허에 인용된 특허 (37)
Dan Engelbreth CA; Robert Morton CA; Martin Foley CA; Mark Nagel CA; Jolyon P. Mitchell CA, Aerosol medication delivery apparatus and system.
Pazirandeh Mehran ; Campbell James R., Bacteria expressing metallothionein gene into the periplasmic space, and method of using such bacteria in environment cl.
Acey,Roger A., Compositions and methods for removing heavy metals from contaminated samples using membranes provided with purified metallothionein (MT) proteins.
Altermatt Daniel (Mnchenstein CHX) Hilpert Hanspeter (Rheinfelden/Nollingen DEX) Khanna Satish C. (Bottmingen CHX) Dubach Werner F. (Maur CHX) Spaltenstein Anton (Bassersdorf CHX), Inhaler.
Lerner Richard A. (La Jolla CA) Roberts Victoria A. (San Diego CA) Getzoff Elizabeth D. (San Diego CA) Tainer John A. (San Diego CA) Benkovic Stephen J. (State College PA), Metal binding proteins.
Andreas Dusterhoft DE; Thomas Manz DE; Ehrenfried Mehl DE; Friedrich Lottspeich DE, Method for producing microporous elements, the microporous elements thus produced and uses thereof.
Barbas Carlos F. (San Diego CA) Rosenblum Jonathan (San Diego CA) Lerner Richard A. (La Jolla CA), Methods for producing polypeptide metal binding sites and compositions thereof.
Peterson Steven F. (West Linn OR) McKinnon ; Jr. Charles N. (Laguna Niguel CA) Smith Paul E. (Tualatin OR) Nakagawa Takaaki (Tigard OR) Bartholomew Victor L. (Tigard OR), Needleless hypodermic injection methods and device.
Clark Wesley D. (26870 Taaffe Road Los Altos Hills CA 94022) Hollenbeck Keith E. (847 Tulane Court Mountain View CA 94040), Needleless hypodermic injector.
Spears Dennis R. (Tuscaloosa AL) Vincent John B. (Tuscaloosa AL), Process for recovering metals from solution utilizing metalloprotein affinity chromatography.
Spears Dennis R. (Tuscaloosa AL) Vincent John B. (Tuscaloosa AL), Process for recovering metals from solution utilizing metalloprotein affinity chromatography.
Takeshi Sano ; Alexander N. Glazer ; Charles R. Cantor, Recombinant streptavidin-metallothionein chimeric protein having biological recognition specificity.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.